You are here

Personalized medicine

disease chart
11.05.2017

New developments in genetic databases will make it easier than ever to identify the molecular basis of disease

 Metastatic melanoma cells. Image: NIH
08.07.2015

Scientists can now begin to make sense of the way a deadly cancer develops

DNA repair mechanism. Image: Wikimedia Commons
28.04.2014

A combined DNA repair score can reveal an individual’s chances of developing lung cancer

Weizmann Institute of Science and Clalit Health Services Will Collaborate to Advance the Field of Personalized Medicine and Improve Health Care Services
10.03.2014

Weizmann Institute scientists, Clalit Health Services physicians and legal advisor, and information system experts from both organizations...

The Weizmann Institute of Science Receives 120 Million Dollars to Establish the Nancy and Stephen Grand Israel National Center for Personalized Medicine
11.11.2013
The Weizmann Institute of Science is establishing, on its campus, the Nancy and Stephen Grand Israel National Center for...
Pre-leukemic stem cells (top) with both mutated and healthy copies of the RUNX1 gene already display some of the characteristics of acute myeloid leukemia (AML). When the non-mutated copy of the gene is inactivated, disruptions in the spindle-assembly-checkpoint phase of cell division trigger cell death
29.09.2013

Weizmann Institute researchers discover that a “standoff” between a mutated gene and its normal counterpart keeps certain cancer cells alive...

New Developments
19.05.2013

 

 
Non-invasive image from the bioimaging center showing blood (red) and lymphatic (green) vessels that were induced to grow by, and in tum facilitate progression of a growing tumor (blue).The ability of tumors to induce local expansion of blood and lymphatic vessels is a critical step in tumor progression and metastatic spread. Targeting these vessels provides an important strategy for novel anti-cancer treatment. Image courtesy Prof. Michal Neeman
16.05.2013
New initiatives and construction at the Weizmann Institute
“Deregulation scores” of hundreds of brain tumor patients: Each row corresponds to a pathway (that is, a biochemical process), and each column to a sample taken from a patient. Every colored spot stands for a number – the value of the “deregulation score” of the corresponding pathway, as determined for a particular patient. Dark blue stands for the activity of the pathway in normal brain tissue, whereas dark red indicates a high level of deviation from normal behavior. The clearly distinct group of normal b
13.05.2013

A new approach to personalized cancer therapy profiles a tumor by its biological pathways

Pages